Showing 1001-1010 of 3019 results for "".
Pearls for Monitoring and Managing Itch: An Expert Panel
https://practicaldermatology.com/topics/atopic-dermatitis/pearls-for-monitoring-and-managing-itch-an-expert-panel/27172/A three-person panel covered the topic of itch recently at The Dermatology Education Foundation’s DEF Essential Resource Meeting 2024 (DERM2024) NP/PA CME Conference in Las Vegas, Nevada, with David Cohen, MD, MPH, leading “How to Avoid Doctor Strange: Pearls for Monitoring and Managing Itch.” Dr. CHumira Approved for HS, NewDerm LIVE Hits Hollywood
https://practicaldermatology.com/topics/psoriasis/dermwiretv-humira-approved-for-hs-newderm-live-hits-hollywood/18831/AbbVie's Humira has become the first and only FDA-approved therapy for adults with moderate to severe hidradenitis suppurativa. NewDermLIVE, a new meeting for dermatologists new to practice—and those not so new to practice—has brought a new kind of meeting into the dermatology space. Solta MedicaKALMing the Itch: Improving QoL in Patients with CKD-aP
https://practicaldermatology.com/programs/cme/kalming-the-itch-improving-qol-in-patients-with-ckd-ap/14966/Join our experts to find ways to effectively manage your patients with CKD-aP and improve their quality of life using evidence-based approved therapy.DermWireTV: AbbVie's Science of Skin Panel, Monkeypox Warning, Recommendations on Skin Cancer Detection Devices, UV Filters and Aquatic Life
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-abbvies-science-of-skin-panel-monkeypox-warning-recommendations-on-skin-cancer-detection-devices-uv-filters-and-aquatic-life/20131/“The Science of Skin: United Beyond the Surface” program sponsored by AbbVie brings together leading dermatologists and patients or caregivers of patients with dermatologic disease to explore the burden of skin diseases on diverse populations and the need for optimized treatment approaches. Seemal DBiosimilar Recommended; Saunders to Head New Pfizer/Allergan Organization
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-biosimilar-recommended-saunders-to-head-new-pfizer-allergan-organization/18825/An FDA committee has recommended Pfizer's Inflectra, biosimilar to infliximab, developed by Celltrion. Sunbelt Melanoma Trial finds no benefit for IFN in Phase III melanoma. Pfizer/Allergan provides details on structure of new organization and announces leadership, including President and COO BrentMerkel Cell Carcinoma Update
https://practicaldermatology.com/topics/skin-cancer-photoprotection/merkel-cell-carcinoma-update/20217/News that “Margaritaville” singer Jimmy Buffett died from Merkel cell carcinoma is shining a spotlight on this rare and aggressive form of skin cancer. Leonel Hernandez Aya, MD, a medical oncologist specializing in skin cancers at the Sylvester Comprehensive Cancer Center at the University of MiamiFrom SDPA: JAKs, Black Boxes, and What It All Means
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-jaks-black-boxes-and-what-it-all-means/26286/Practitioners shouldn’t fear Janus kinase (JAK) inhibitors for their patients when appropriate, according to a wide-ranging expert chat at the 2024 SDPA Annual Summer Conference in San Diego. The conversation featured Matthew Zirwas, MD, a dermatologist with DOCS Dermatology, and Amy Spizuoco, DO, FHow do you manage a complex medical referral?
https://practicaldermatology.com/topics/practice-management/how-do-you-manage-a-complex-medical-referral-/18794/Management of complex medical dermatology referrals has evolved, says Joseph Jorizzo, MD, FAAD, Professor; Former & Founding Chair, Dermatology Dept., Wake Forest University and Professor of Dermatology, Weill Cornell Medical College. In this edition of Ask an Expert, he talks to host Adam FriedUV-B Phototherapy for Psoriasis: Comparing Home-Based and Office-Based Treatment
https://practicaldermatology.com/programs/frontlines-psoriasis/uv-b-phototherapy-for-psoriasis-comparing-home-based-and-office-based-treatment/26302/Dive into the results of the LITE study, which examines patient outcomes after home phototherapy versus office phototherapy.Expanded Options in Adjuvant Immunotherapy for Resectable Melanoma: A Multidisciplinary Conversation
https://practicaldermatology.com/programs/cme/expanded-options-in-adjuvant-immunotherapy-for-resectable-melanoma-a-multidisciplinary-conversation/18065/Tune in to learn best practices for using adjuvant systemic therapy and appropriate agents for stage IIB-IV resectable melanoma patients.